Drugmakers, hospitals at odds over 340B discounts

02/12/2013 | New York Times (tiered subscription model), The

The pharmaceutical industry and hospitals are fighting over the federally mandated 340B drug discount program. Some hospitals use the program as a revenue source instead of to help poor patients, drug industry groups say in a report. Hospitals argue that 340B was designed to stretch resources and support hospitals that serve the poor. Congressional Republicans are looking into the program.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief: